Dr. Karlee Ausk Joins Washington Gastroenterology in Bellevue
17 juil. 2024 10h35 HE
|
GI Alliance
Bellevue, WA, July 17, 2024 (GLOBE NEWSWIRE) -- Washington Gastroenterology is proud to welcome Dr. Karlee Ausk, a board-certified physician experienced in treating all gastrointestinal diseases,...
Global Gut Microbiota Markets, Insights and Forecasts to 2031 - Key Players Danone, IFF, Ferring, and Nestle Focusing on R&D and Strategic Partnerships
12 juil. 2024 05h35 HE
|
Research and Markets
Dublin, July 12, 2024 (GLOBE NEWSWIRE) -- The "Gut Microbiota Market, By Product, By Application, By Disease Type, By End Users, By Distribution Channel: By Region - Market Size, Industry Dynamics,...
Dr. Po-Hong Liu Joins Washington Gastroenterology in Federal Way, Washington
09 juil. 2024 10h40 HE
|
GI Alliance
Federal Way, WA, July 09, 2024 (GLOBE NEWSWIRE) -- Washington Gastroenterology is excited to welcome Dr. Po-Hong Liu, and experienced physician who treats all gastrointestinal and liver diseases who...
Dr. Charles McDaniel Joins Texas Digestive Disease Consultants in Sunnyvale, Texas
08 juil. 2024 08h40 HE
|
GI Alliance
Sunnyvale, TX, July 08, 2024 (GLOBE NEWSWIRE) -- Texas Digestive Disease Consultants is excited to welcome Dr. Charles McDaniel, a board-certified physician who treats all gastrointestinal disorders...
Global Continuing Medical Education Market to Reach USD 18.45 billion by 2032, Experiencing Steady Growth at a 7.72% CAGR | Straits Research
04 juil. 2024 09h35 HE
|
Straits Research Private Limited - Garner Insights
New York, United States, July 04, 2024 (GLOBE NEWSWIRE) -- As per the latest report by Straits Research, the global continuing medical education market size was valued at USD 9.45 billion in 2023....
Dr. Eric Lorio Joins Metropolitan Gastroenterology Associates in Marrero, Louisiana
27 juin 2024 07h40 HE
|
GI Alliance
Marrero, LA, June 27, 2024 (GLOBE NEWSWIRE) -- Metropolitan Gastroenterology Associates is proud to welcome Dr. Eric Lorio. Board certified in Internal Medicine, Dr. Lorio provides patient-centered...
Dupixent® (dupilumab) Positive Phase 3 Data in Children 1 to 11 Years of Age with Eosinophilic Esophagitis Published in the New England Journal of Medicine
26 juin 2024 17h30 HE
|
Regeneron Pharmaceuticals, Inc.
Majority of patients in this age group with eosinophilic esophagitis (EoE) receiving Dupixent achieved histologic remission, with improvements sustained up to one year Dupixent is the first and only...
Specialists in Gastroenterology and GI Alliance Begin Prescribing Groundbreaking Rezdiffra for Fatty Liver Disease
26 juin 2024 08h30 HE
|
GI Alliance
St. Louis, MO, June 26, 2024 (GLOBE NEWSWIRE) -- Specialists in Gastroenterology (SIG) and GI Alliance are excited to announce that Dr. Leonard Weinstock and other GI Alliance gastroenterologists...
US Gastroenterologists Express Anticipation for Approval of AbbVie’s Skyrizi in Ulcerative Colitis, Projecting Rapid Adoption Post-Launch
12 juin 2024 12h18 HE
|
Spherix Global Insights
EXTON, PA, June 12, 2024 (GLOBE NEWSWIRE) -- Despite being the second IL-23 inhibitor to enter the market, AbbVie’s Skyrizi (risankizumab) is expected to have a substantial impact on ulcerative...
Dr. Harry E. Sarles Jr. Honored with Distinguished Alumni Award by UTMB
05 juin 2024 08h43 HE
|
GI Alliance
Dallas, TX, June 05, 2024 (GLOBE NEWSWIRE) -- The University of Texas Medical Branch (UTMB) is proud to announce that Dr. Harry E. Sarles, Jr., MD, MACG, AGAF, has been named a recipient of the...